Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Mounjaro (tirzepatide) : Approved by the FDA in 2022 for the management of type 2 diabetes
The capsules are shelf-stable and can be stored in a cool, dry place
Clinicians should guide their patients through the benefits and limitations of each to ensure safe and informed decisions
However, CMS clarified in a memo dated March 20, 2024, that anti-obesity medications that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use. As of August 19, 2024, the only GLP-1 RA this applies to is Wegovy, which, in addition to its obesity indication, is also indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight
Saldanha AJ
US$ 24.64
US$ 28.34
US$ 29.81
US$ 24.48
US$ 28.53
US$ 25.91
